Yusuf Hamied

Pharmaceuticals, Mumbai. Hamied led Cipla, the generic drug maker his father founded in 1935, and in 2001 offered a triple-combination HIV treatment to Médecins Sans Frontières for about a dollar a day, a fraction of the branded price. The offer helped transform access to antiretrovirals across Africa and the developing world. Cipla's strength was cheap, high-quality manufacturing under India's process-patent rules of the time.